Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BIOX
BIOX logo

BIOX Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
0.460
Open
0.425
VWAP
0.44
Vol
724.21K
Mkt Cap
28.46M
Low
0.412
Amount
318.17K
EV/EBITDA(TTM)
--
Total Shares
63.82M
EV
281.46M
EV/OCF(TTM)
--
P/S(TTM)
--
Bioceres Crop Solutions Corp. is a provider of crop productivity technologies designed to enable the transition of agriculture towards carbon neutrality. Its segments include Seed and integrated products, Crop protection and Crop nutrition. Seed and integrated products segment focuses on the development and commercialization of seed technologies and products, including provision of seed technologies integrated with crop protection and crop nutrition products designed to control weeds, insects or diseases, to increase their quality characteristics. Crop protection segment includes the development, production and marketing of adjuvants and a range of pest control molecules and biocontrol products. Crop nutrition segment focuses on the development, production and commercialization of inoculants that allow the biological fixation of nitrogen in the crops, and of fertilizers, including biofertilizers and micro-granulated fertilizers that optimize the productivity and yield of the crops.
Show More

Events Timeline

(ET)
2026-05-11
17:10:00
Bioceres Reports Q3 Revenue of $39.4M
select
2026-03-16 (ET)
2026-03-16
08:10:00
Bioceres CEO Discusses Financial Challenges and Restructuring Plans
select
2025-12-31 (ET)
2025-12-31
12:10:00
Bioceres Crop Solutions Appoints New CFO and Board Member
select
link
2025-09-23 (ET)
2025-09-23
07:05:26
Bioceres and Colorado Wheat Research Foundation Collaborate on HB4 Wheat Commercialization
select
2025-09-09 (ET)
2025-09-09
06:03:26
Bioceres announces Q4 revenue of $74.7M, falling short of consensus estimate of $110.08M
select

News

Yahoo Finance
9.5
05-12Yahoo Finance
Bioceres Crop Solutions Earnings Call Insights
  • Revenue Decline: Bioceres Crop Solutions reported a 23% year-over-year decline in total revenue, primarily due to softer market conditions and ongoing portfolio transitions, which places financial pressure on the company and impacts future growth potential.
  • Significant Gross Profit Drop: The company's gross profit fell by 30% year-over-year, with broad declines across all segments, indicating severe challenges to profitability in the current market environment, necessitating measures to improve financial health.
  • Growth in Crop Nutrition: Despite the overall revenue decline, the crop nutrition segment achieved a 15% year-over-year growth, driven by increased demand for microbeaded fertilizers, suggesting that this area still holds growth potential and could become a future business highlight.
  • Litigation Risks: The company is facing ongoing litigation related to the ProFarm Group, involving a non-cash impairment loss of approximately $179 million, which adds financial uncertainty and could affect investor confidence and stock performance.
seekingalpha
9.5
05-12seekingalpha
Bioceres Crop Solutions Reports Q3 Fiscal 2026 Earnings Decline Amid Transition
  • Declining Financial Performance: Bioceres Crop Solutions reported total revenues of $39.4 million for Q3, reflecting a 23% year-over-year decline primarily due to an 18% drop in Crop Protection revenue to $24.6 million, while Seeds and Integrated Products revenue plummeted 71%, indicating significant competitive pressures in the market.
  • Gross Margin Contraction: The gross profit for the quarter was $12.7 million, down from $18.1 million last year, with gross margin decreasing from 35% to 32%, highlighting challenges in cost control and the impact of product mix effects and nonrecurring adjustments on profitability.
  • Increased Liquidity Risk: As of March 31, 2026, the company reported total financial debt of approximately $229 million, with cash and short-term investments totaling only $14 million, resulting in a net financial debt of about $214 million, underscoring urgent liquidity management concerns.
  • Litigation Risk: The company faces heightened litigation risks as four holders of secured notes filed a lawsuit in New York, and while the company strongly disputes these allegations, the case remains in its early stages, potentially impacting future financial stability.
seekingalpha
9.5
05-12seekingalpha
Bioceres Reports Q3 Loss Amid Revenue Decline
  • Poor Financial Performance: Bioceres reported a net loss of $10 million in Q3, with an adjusted EBITDA of negative $0.6 million, indicating significant challenges in profitability.
  • Significant Revenue Decline: The company's revenue of $39.4 million represents a 22.9% year-over-year decrease, missing expectations by $15.1 million, reflecting weak market demand and increased competition.
  • Market Reaction: Despite Bioceres' disappointing results, fertilizer stocks rallied due to supply fears in the Middle East, indicating heightened market interest and investor sentiment volatility.
  • Uncertain Future Outlook: Given the current economic environment, Bioceres' financial performance may impact its future investment and expansion plans, necessitating close monitoring of the company's strategic adjustments and market responses.
Newsfilter
9.5
03-16Newsfilter
Bioceres Reports Q2 Financial Results Amid Challenges
  • Financial Performance Pressure: Bioceres' Q2 financial results reveal revenue and working capital impacts due to sustained pressure on Argentine farmer economics, although the consolidated gross margin across its three business segments remains at 40%, demonstrating the resilience of its technology-driven product portfolio.
  • Asset Disposal and Impairment: A foreclosure auction for Pro Farm assets occurred on January 20, 2026, with a bid of $15 million against a carrying value of approximately $194 million, resulting in a $179 million impairment loss, highlighting significant financial challenges faced by the company.
  • Financing and Capital Structure: The company continues to face substantial doubt regarding its ability to secure additional financing, actively engaging with local Argentine financial institutions to refinance obligations while evaluating asset disposals and long-term financing options to restore market confidence and improve capital structure.
  • Board Governance Strengthening: Bioceres has strengthened its board by adding two new non-executive directors in Q2 of fiscal 2026, focusing on enhancing governance and independent oversight to navigate current challenges and ensure transparency with shareholders.
seekingalpha
2.0
03-13seekingalpha
Middle East Tensions Drive Fertilizer Stocks Rally
  • Market Reaction: Fertilizer stocks have rallied recently as escalating tensions in the Middle East raise concerns about nitrogen supply disruptions, with producers like CF Industries, Nutrien, and Mosaic seeing significant price increases reflecting market expectations of tighter availability.
  • Supply Chain Risks: Nearly half of global urea exports and about 30% of ammonia shipments originate from conflict-affected regions, raising supply concerns just as the Northern Hemisphere's spring planting season approaches, potentially impacting crop production.
  • Cost Advantage: Rising natural gas prices in Europe, a key feedstock for nitrogen fertilizer production, are widening the cost advantage for U.S. producers, enhancing their competitiveness in the global market.
  • Quant Rating Performance: Within the fertilizer sector, Intrepid Potash and Mosaic have received “Strong Buy” and “Hold” ratings respectively, with 5-day performances of 3.97% and 15.75%, indicating strong market confidence in these companies.
stocktwits
8.5
02-13stocktwits
Moolec Achieves Breakthrough Results and Stock Market Reaction
  • Increased Planting and Yields: Moolec cultivated approximately 1,100 acres of engineered safflower in the 2025 season, achieving an average yield of 2,200 pounds per acre, significantly up from 1,400 pounds in 2024, exceeding the company's expectations and demonstrating the effectiveness and potential of its agricultural technology.
  • GLA Concentration Validation: The company confirmed gamma-linolenic acid (GLA) concentrations of around 45% from its U.S. GLASO safflower platform, marking the operational feasibility of its plant-engineered molecular farming technology for commercial-scale production, laying the groundwork for sustainable revenue.
  • Nasdaq Listing Approval: On January 30, Moolec confirmed that the Nasdaq Hearings Panel approved its request for continued listing after the company regained compliance with minimum bid price requirements following a one-for-15 reverse stock split, boosting market confidence.
  • Positive Stock Market Reaction: Following the announcement of strong crushing results, Moolec's shares soared over 130% on Friday, with the stock gaining 241% year-to-date, reflecting strong investor optimism regarding its future growth prospects.
Wall Street analysts forecast BIOX stock price to rise
1 Analyst Rating
Wall Street analysts forecast BIOX stock price to rise
0 Buy
1 Hold
0 Sell
Hold
Current: 0.000
sliders
Low
2.00
Averages
2.00
High
2.00
Current: 0.000
sliders
Low
2.00
Averages
2.00
High
2.00
Canaccord
Austin Moeller
Hold
downgrade
$2
AI Analysis
2026-01-02
Reason
Canaccord
Austin Moeller
Price Target
$2
AI Analysis
2026-01-02
downgrade
Hold
Reason
Canaccord analyst Austin Moeller lowered the firm's price target on Bioceres to $2 from $2.25 and keeps a Hold rating on the shares. On December 18, New York's Supreme Court ruled against Bioceres in ongoing litigation with the company's creditors, the analyst tells investors in a research note. The firm says that with the judge's non-final verdict determined, a credit sale process of Bioceres' Pro Farm assets will likely now ensue. It believes the process could be damaging to the company's operations.
Canaccord
Hold
downgrade
2025-11-14
Reason
Canaccord
Price Target
2025-11-14
downgrade
Hold
Reason
Canaccord lowered the firm's price target on Bioceres to $2.25 from $2.50 and keeps a Hold rating on the shares. The firm reported lower Q1 revenues and adjusted EBITDA. The company has executed well on management's previously stated business priorities, including efforts to improve the business's margin profile, reduce operating expenses and better manage WC. Management cited expectations for the sustained unwinding of the seed business to temporarily lower upfront revenue recognition for the next two quarters in the segment.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BIOX
Unlock Now

Valuation Metrics

The current forward P/E ratio for Bioceres Crop Solutions Corp (BIOX.O) is 14.99, compared to its 5-year average forward P/E of 23.83. For a more detailed relative valuation and DCF analysis to assess Bioceres Crop Solutions Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
23.83
Current PE
14.99
Overvalued PE
37.76
Undervalued PE
9.90

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
10.21
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
12.24
Undervalued EV/EBITDA
8.18

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.38
Current PS
0.00
Overvalued PS
1.91
Undervalued PS
0.84

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

us stock are fine.
Intellectia · 791 candidates
Region: USPrice: >= $-100.00Rsi Category: moderateMoving Average Relationship: PriceAboveMA20Week Price Change Pct: >= $-3.00Ema 20: >= -100One Week Rise Prob: >= 55
Ticker
Name
Market Cap$
top bottom
STIM logo
STIM
Neuronetics Inc
98.80M
MMS logo
MMS
Maximus Inc
3.77B
FF logo
FF
FutureFuel Corp
184.67M
SOPH logo
SOPH
SOPHiA GENETICS SA
378.41M
ARTNA logo
ARTNA
Artesian Resources Corp
334.83M
SG logo
SG
Sweetgreen Inc
816.13M

Whales Holding BIOX

F
Fourth Sail Capital LP
Holding
BIOX
-14.20%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Bioceres Crop Solutions Corp (BIOX) stock price today?

The current price of BIOX is 0.4459 USD — it has increased 4.94

What is Bioceres Crop Solutions Corp (BIOX)'s business?

Bioceres Crop Solutions Corp. is a provider of crop productivity technologies designed to enable the transition of agriculture towards carbon neutrality. Its segments include Seed and integrated products, Crop protection and Crop nutrition. Seed and integrated products segment focuses on the development and commercialization of seed technologies and products, including provision of seed technologies integrated with crop protection and crop nutrition products designed to control weeds, insects or diseases, to increase their quality characteristics. Crop protection segment includes the development, production and marketing of adjuvants and a range of pest control molecules and biocontrol products. Crop nutrition segment focuses on the development, production and commercialization of inoculants that allow the biological fixation of nitrogen in the crops, and of fertilizers, including biofertilizers and micro-granulated fertilizers that optimize the productivity and yield of the crops.

What is the price predicton of BIOX Stock?

Wall Street analysts forecast BIOX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BIOX is2.00 USD with a low forecast of 2.00 USD and a high forecast of 2.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Bioceres Crop Solutions Corp (BIOX)'s revenue for the last quarter?

Bioceres Crop Solutions Corp revenue for the last quarter amounts to 38.20M USD, decreased -35.90

What is Bioceres Crop Solutions Corp (BIOX)'s earnings per share (EPS) for the last quarter?

Bioceres Crop Solutions Corp. EPS for the last quarter amounts to -0.14 USD, increased 600.00

How many employees does Bioceres Crop Solutions Corp (BIOX). have?

Bioceres Crop Solutions Corp (BIOX) has 751 emplpoyees as of May 31 2026.

What is Bioceres Crop Solutions Corp (BIOX) market cap?

Today BIOX has the market capitalization of 28.46M USD.